Tag: neurological disorders
EMVision’s neuroimaging advancements fueled by $15.28M from Keysight Technologies
EMVision Medical Devices Limited announced a strategic AUD 15.28 million investment from Keysight Technologies Inc, to bolster the former's neuroimaging technology and its potential to revolutionise diagnosis and treatment outcomes for neurological disorders.
Featured Article
AMCA Impact Study highlights AI’s role in improving HVAC safety compliance
A new AMCA Impact Study has highlighted the growing challenge of helping HVAC contractors access reliable safety and compliance information quickly, particularly for small and medium-sized businesses operating in Australia's highly regulated construction environment.
